Human Insulin Global Market Forecast by 2020
©
About Human Insulin
Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produce sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.
Read more at: http://www.researchbeam.com/global-human-insulin-2015-2019-market
Researchbeam's analysts forecast the Global Human Insulin Market to Grow at A CAGR of 10.29% Over The Period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes.
Researchbeam's report, Global Human Insulin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.
Key vendors
• Eli Lilly
• Novo Nordisk
• Sanofi
Other prominent vendors
• Biocon
• Biodel
• Biogenomics
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Diamyd Medical
• Diasome Pharmaceuticals
• DiaVacs
• Pfizer
• Generex Biotechnology
• Lexicon Pharmaceuticals
• Macrogenics
• Merck
• Oramed Pharmaceuticals
• Osiris Therapeutics
• Thermalin Diabetes
• Tolerion
• Wockhardt
• XOMA Corporation
Market driver
• Increase in prevalence of diabetes
• For a full, detailed list, view our report
Market challenge
• Stringent regulatory environment
• For a full, detailed list, view our report
Market trend
• Increasing R&D for novel mechanisms
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Request report sample @ http://www.researchbeam.com/global-human-insulin-2015-2019-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology
Research methodology
Economic indicators
PART 05: Disease overview
Epidemiology
PART 06: Pipeline analysis
PART 07: Introduction
Key market highlights
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/
Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produce sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.
Read more at: http://www.researchbeam.com/global-human-insulin-2015-2019-market
Researchbeam's analysts forecast the Global Human Insulin Market to Grow at A CAGR of 10.29% Over The Period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes.
Researchbeam's report, Global Human Insulin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.
Key vendors
• Eli Lilly
• Novo Nordisk
• Sanofi
Other prominent vendors
• Biocon
• Biodel
• Biogenomics
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Diamyd Medical
• Diasome Pharmaceuticals
• DiaVacs
• Pfizer
• Generex Biotechnology
• Lexicon Pharmaceuticals
• Macrogenics
• Merck
• Oramed Pharmaceuticals
• Osiris Therapeutics
• Thermalin Diabetes
• Tolerion
• Wockhardt
• XOMA Corporation
Market driver
• Increase in prevalence of diabetes
• For a full, detailed list, view our report
Market challenge
• Stringent regulatory environment
• For a full, detailed list, view our report
Market trend
• Increasing R&D for novel mechanisms
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Request report sample @ http://www.researchbeam.com/global-human-insulin-2015-2019-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology
Research methodology
Economic indicators
PART 05: Disease overview
Epidemiology
PART 06: Pipeline analysis
PART 07: Introduction
Key market highlights
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/